LENZ Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
LENZ Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2023.
  • LENZ Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $1.75M, a 32.5% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $44.1M, a 615% increase from 2022.
  • LENZ Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $6.17M, a 203% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.75M +$428K +32.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $1.32M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.